PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer - American Urological Association
JCM | Free Full-Text | New Biopsy Techniques and Imaging Features of Transrectal Ultrasound for Targeting PI-RADS 4 and 5 Lesions
PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml - ScienceDirect
Alo Dòk La/ Allô Dr? - #346 Allô Dr? "Au Labo" PSA L'antigène spécifique de la prostate (PSA) est une protéine de 33 kd constituée d'une glycoprotéine à chaîne unique de 237
Distribution of serum PSA values and age groups in the present... | Download Table
SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
PSA cut point of more than 0.4 ng/mL predicts progression
Distribution of serum PSA values and age groups in the present... | Download Table
Understanding PSA and other prostate cancer screenings | Prolaris
PSA: Why 1.5 is the New 4?
PSA Testing | ZERO Prostate Cancer
Fluorescence response of the assay in the presence of PSA (5 ng·mL −1... | Download Scientific Diagram
PSA Testing | ZERO Prostate Cancer
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
Some patients with prostate cancer have elevated | Chegg.com
